CJC-1295 (no DAC): What It Is and How It's Used in the Philippines

Quick read: CJC-1295 without DAC (also called Modified GRF 1-29) is a short-acting GHRH analog that creates a GH pulse lasting 30-120 minutes. Dosed at 100mcg before bed, it's almost always stacked with Ipamorelin for synergistic GH release. In PH, it's the preferred option over the DAC version for users who want pulsatile GH release that mimics natural rhythms.

What it is

CJC-1295 without DAC is a synthetic analog of growth hormone releasing hormone (GHRH). It's also called Modified GRF 1-29 or Mod GRF. The "no DAC" refers to the absence of the Drug Affinity Complex that extends half-life.

Without DAC, the peptide has a half-life of roughly 30 minutes. It creates a GH pulse that peaks within 30-60 minutes and returns to baseline within 2-3 hours. This mimics the body's natural pulsatile GH release (which happens in 3-5 pulses per day, with the largest pulse occurring during deep sleep).

The mechanism: CJC-1295 (no DAC) binds to GHRH receptors on pituitary somatotrophs and triggers GH release. Unlike GHRP-class peptides (Ipamorelin, GHRP-2/6), which mimic ghrelin, CJC works through the GHRH pathway. The two mechanisms synergize, which is why CJC (no DAC) is almost always stacked with Ipamorelin.

Research on CJC-1295 (no DAC) shows it significantly increases GH and IGF-1 when dosed before bed. The pulsatile release is thought to be more physiological (and potentially safer) than the sustained elevation seen with CJC-1295 with DAC.

In the PH peptide community, CJC-1295 (no DAC) is the default GH secretagogue. It's almost always run as part of the CJC + Ipamorelin protocol, rarely alone.

What it's used for

Primary use: Body recomposition and recovery. CJC-1295 (no DAC) + Ipamorelin is the most common GH stack for fat loss, muscle retention during cuts, improved recovery, and sleep quality.

Secondary use: Anti-aging and sleep improvement. Elevated GH improves sleep depth and supports collagen synthesis, skin quality, and hair health.

Tertiary use: Injury recovery support. GH supports soft tissue healing, though CJC (no DAC) is less commonly used for this purpose than BPC-157 or TB-500.

Realistic expectations: Users running CJC (no DAC) + Ipamorelin for 8-12 weeks typically report better sleep, faster recovery, slight fat loss (especially visceral), and improved muscle fullness. The effects are subtle and cumulative.

Typical protocols

CJC-1295 (no DAC) is almost never run alone. The standard protocol is CJC + Ipamorelin before bed.

Standard CJC (no DAC) + Ipamorelin protocol:

• Dose: 100mcg CJC + 200-300mcg Ipamorelin, subcutaneous
• Timing: Before bed, on an empty stomach (2-3 hours after last meal)
• Frequency: Daily
• Duration: 8-12 weeks, then cycle off for 4-8 weeks

Conservative protocol:

• Dose: 100mcg CJC + 200mcg Ipamorelin
• Frequency: 5-6 nights per week (skip 1-2 nights)
• Duration: 8 weeks

Aggressive protocol (advanced users):

• Dose: 100mcg CJC + 300-500mcg Ipamorelin
• Frequency: Daily, sometimes 2x daily (morning and before bed)
• Duration: 12 weeks

Pin location: Subcutaneous, typically abdomen or thigh.

Reconstitution: CJC-1295 (no DAC) typically comes as 2mg lyophilized powder. A common reconstitution is 2mg + 2mL bacteriostatic water = 1mg/mL. For 100mcg, that's 0.1mL (10 units).

Timing matters: Pin before bed to align with the body's natural nocturnal GH pulse.Empty stomach is important: food (especially carbs) blunts GH release.

What users typically report

Week 1-2: Sleep quality improves. Users report deeper sleep, more vivid dreams, and feeling more rested upon waking. Recovery between training sessions may improve slightly.

Week 3-4: Body composition changes start to show. Slight fat loss (especially around the midsection), improved muscle fullness. Strength may improve slightly. Skin quality may improve.

Week 5-8: Continued recomposition. Users in a caloric deficit report better muscle retention. Users at maintenance report slow fat loss with stable muscle mass.

Week 9-12: Effects plateau. Most benefit happens in the first 6-8 weeks.

Variance: Older users (35+) with declining GH tend to respond better than younger users. Response also depends on sleep quality, training stimulus, and nutrition.

From PH community logs, the CJC (no DAC) + Ipamorelin stack is one of the most consistently effective peptide protocols for body recomposition and recovery.

Common side effects

Side effects are rare and mild with CJC (no DAC) alone. Most sides come from the Ipamorelin component or from excessively high doses.

Mild flushing or warmth (5-10%): Shortly after injection, some users feel a warm flush. This resolves within 20-30 minutes.

Increased hunger (5%): Some users report feeling hungrier, likely due to elevated ghrelin signaling (from Ipamorelin, not CJC).

Vivid dreams (10-15%): More intense or vivid dreams during the first few weeks. Not harmful, just unusual.

Injection site irritation (5%): Redness or mild swelling.

Headache (rare, <5%): Occasionally reported.

Serious side effects are not documented at typical doses. CJC (no DAC) doesnt cause the numbness/tingling or water retention sometimes seen with CJC (with DAC).

Side effect management

Flushing: Not harmful, resolves quickly. If bothersome, reduce dose.

Increased hunger: Track calories if running for fat loss. Pin later at night if hunger interferes with sleep.

Vivid dreams: Not harmful. If bothersome, try reducing dose or pinning earlier in the evening.

Injection site irritation: Rotate sites. Use fresh needles.

Headache: Stay hydrated. If persistent, reduce dose.

Who this compound is for

CJC-1295 (no DAC) is for people running the CJC + Ipamorelin stack for body recomposition, recovery, or anti-aging. The ideal user is:

• Someone 30+ looking to improve recovery and body composition
• Someone running a fat loss protocol who wants to preserve muscle
• Someone training 4-6x weekly who needs better recovery
• Someone who values natural GH pulsatility over sustained elevation

It's popular in the PH peptide community among users 35-55 who want a science-backed, well-tolerated GH protocol.

Who this compound is NOT for

CJC-1295 (no DAC) alone is not particularly effective. It should be stacked with Ipamorelin for synergistic GH release.

Active cancer: GH and IGF-1 elevation could theoretically promote tumor growth.

Type 1 or poorly controlled type 2 diabetes: GH can worsen insulin resistance.

Pregnancy and breastfeeding: No safety data.

People unwilling to pin daily: CJC (no DAC) requires daily dosing for consistent results.

PH-specific considerations

Preferred for natural rhythm: PH users generally prefer CJC (no DAC) over CJC (with DAC) because the pulsatile release mimics natural GH rhythms and may be safer long-term.

Fits well with PH sleep schedule: Pinning before bed aligns with Filipino sleep patterns (10pm-6am typical). The GH pulse happens during deep sleep, which is when natural GH peaks.

Cost: CJC (no DAC) is slightly cheaper per vial than CJC (with DAC), but requires daily dosing, so total cost over a cycle is similar.

Tropical climate storage: Refrigerate after reconstitution. Unreconstituted powder tolerates brief temperature fluctuations.

Common stacks

CJC (no DAC) + Ipamorelin: The standard stack. See CJC + Ipa Protocol for details.

CJC (no DAC) + Ipa + BPC-157 + TB-500: For comprehensive recovery and healing.

CJC (no DAC) + Ipa + Retatrutide: For muscle preservation during aggressive fat loss.

Things to watch

Bloodwork:

• Baseline IGF-1, fasting glucose
• Recheck IGF-1 at week 6-8 (should be elevated but not excessive)

Subjective metrics:

• Sleep quality
• Recovery between sessions
• Body composition (waist circumference)

PH labs offer IGF-1 testing for 1500-2500 PHP.

Coming off / cycling

Stop cold after 8-12 weeks. Cycle off for 4-8 weeks to prevent pituitary desensitization.

Related compounds

• Ipamorelin — Almost always stacked with CJC (no DAC)
• CJC + Ipamorelin Protocol — Full protocol guide
• CJC-1295 with DAC — Long-acting version

Sources

• Teichman 2006 — CJC-1295 pharmacokinetics
• Jetté 2005 — GHRH analog effects on GH pulsatility
• Walker 2009 — Modified GRF effects on body composition

Last updated: 2026-05-20. This page is for educational purposes and does not constitute medical advice. Always consult a qualified healthcare professional before starting any peptide protocol.